“…Altering the TABP in individuals with coronary heart disease (CHD) has been the focus of a research interest (Suinn, 1982). Moreover, a growing number of researchers (e.g., Kelly & Stone, 1987;Roskies, Spevack, Surkis, Cohen, & Gilman, 1978) have directed their attention to modification of the TABP in healthy subjects with the goal of future prevention of CHD.…”